Literature DB >> 22038132

[HPV-associated carcinomas of the female genital tract. Molecular mechanisms of development].

M Reuschenbach1, S Vinokurova, M von Knebel Doeberitz.   

Abstract

Infections with human papillomaviruses (HPV) are a common occurrence in both men and women. In contrast HPV-associated neoplasias are relatively rare and occur only in certain areas of the body. The virus has obviously developed efficient mechanisms for its persistence without inducing too much damage to the host. The formation of neoplasia seems to be more an exception. Epigenetic mechanisms play an important role in the regulation of viral gene expression. Investigations have indicated that exactly the transition from the permissive infection stage to a transformation stage, where neoplastic alterations can occur due to expression of the viral oncogenes, is associated with certain methylation patterns of the viral genome which promote the expression of the oncogenes E6 and E7. The transforming stage is seen as the actual carcinogenic event and can be immunohistochemically detected by the biomarker p16(INK4a).

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22038132     DOI: 10.1007/s00292-011-1474-7

Source DB:  PubMed          Journal:  Pathologe        ISSN: 0172-8113            Impact factor:   1.011


  31 in total

Review 1.  Genomic DNA methylation: the mark and its mediators.

Authors:  Robert J Klose; Adrian P Bird
Journal:  Trends Biochem Sci       Date:  2006-01-05       Impact factor: 13.807

Review 2.  Phenotypic plasticity and the epigenetics of human disease.

Authors:  Andrew P Feinberg
Journal:  Nature       Date:  2007-05-24       Impact factor: 49.962

3.  Beta-papillomavirus DNA loads in hair follicles of immunocompetent people and organ transplant recipients.

Authors:  Sönke Weissenborn; Rachel E Neale; Tim Waterboer; Damiano Abeni; Jan Nico Bouwes Bavinck; Adele C Green; Catherine A Harwood; Sylvie Euvrard; Mariet C W Feltkamp; Maurits N C de Koning; Luigi Naldi; Wim G V Quint; Gianpaolo Tessari; Charlotte M Proby; Ulrike Wieland; Herbert Pfister
Journal:  Med Microbiol Immunol       Date:  2011-07-27       Impact factor: 3.402

4.  Dose-dependent regulation of the early promoter of human papillomavirus type 18 by the viral E2 protein.

Authors:  G Steger; S Corbach
Journal:  J Virol       Date:  1997-01       Impact factor: 5.103

5.  Caveolin-1-dependent infectious entry of human papillomavirus type 31 in human keratinocytes proceeds to the endosomal pathway for pH-dependent uncoating.

Authors:  Jessica L Smith; Samuel K Campos; Angela Wandinger-Ness; Michelle A Ozbun
Journal:  J Virol       Date:  2008-07-30       Impact factor: 5.103

6.  The initial steps leading to papillomavirus infection occur on the basement membrane prior to cell surface binding.

Authors:  Rhonda C Kines; Cynthia D Thompson; Douglas R Lowy; John T Schiller; Patricia M Day
Journal:  Proc Natl Acad Sci U S A       Date:  2009-11-17       Impact factor: 11.205

Review 7.  Papillomaviruses in the causation of human cancers - a brief historical account.

Authors:  Harald zur Hausen
Journal:  Virology       Date:  2009-01-08       Impact factor: 3.616

8.  Human papillomavirus type 31 uses a caveolin 1- and dynamin 2-mediated entry pathway for infection of human keratinocytes.

Authors:  Jessica L Smith; Samuel K Campos; Michelle A Ozbun
Journal:  J Virol       Date:  2007-07-11       Impact factor: 5.103

Review 9.  Transcriptional regulation of the papillomavirus oncogenes by cellular and viral transcription factors in cervical carcinoma.

Authors:  Françoise Thierry
Journal:  Virology       Date:  2008-12-07       Impact factor: 3.616

10.  Human papillomavirus type 16 entry: retrograde cell surface transport along actin-rich protrusions.

Authors:  Mario Schelhaas; Helge Ewers; Minna-Liisa Rajamäki; Patricia M Day; John T Schiller; Ari Helenius
Journal:  PLoS Pathog       Date:  2008-09-05       Impact factor: 6.823

View more
  2 in total

Review 1.  [HPV-associated oropharyngeal carcinoma. Status quo and relationship with cancer of unknown primary].

Authors:  M Mollenhauer; G Assmann; P Zengel; O Guntinas-Lichius; S Ihrler
Journal:  Pathologe       Date:  2014-03       Impact factor: 1.011

2.  [Immunocytochemistry of p16(INK4a) and Ki-67 as adjunctive method for routine gynecological cytology of mild and moderate dysplasia].

Authors:  P Ziemke; K Marquardt
Journal:  Pathologe       Date:  2013-07       Impact factor: 1.011

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.